Final answer:
Following treatment for Hodgkin lymphoma, patients may face a higher risk of secondary cancers including melanoma, non-small cell lung cancer, bladder cancer, and others due to the long-term effects of chemotherapy and radiation therapy.
Step-by-step explanation:
Patients treated for Hodgkin lymphoma are at an increased risk for developing several types of secondary cancers. Such risks are associated with the long-term effects of treatments such as chemotherapy and radiation therapy. These secondary malignancies may include, but are not limited to, melanoma, non-small cell lung cancer, bladder cancer, breast cancer, pancreatic cancer, brain tumors, acute myeloid leukemia, multiple myeloma, and non-Hodgkin's lymphoma. People who have been treated for Hodgkin lymphoma should be monitored for such complications over time, and it's also important to discuss the potential risks with their healthcare provider before beginning treatment.